[1]
“Navigating GIP/ GLP-1 pathophysiology and compounding impacts on T2DM care”, J. Assoc. Clin. Endocrinol. Diabetol. Bangladesh, vol. 4, no. 20, p. S28, Oct. 2025, doi: 10.3329/jacedb.v4i20.84903.